ReviewLipids in health and disease2026
Overview of the effect of dietary supplementation with plant sterols on low-grade inflammation, endothelial dysfunction and oxidative stress in patients with hypercholesterolemia.
Review in Lipids in health and disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Plant sterols (PS) may improve cardiovascular risk biomarkers, beyond their cholesterol-lowering effects. Following PRISMA guidelines, 37 clinical trials evaluating the effect of the PS dietary supplementation on serum lipids, and inflammation, endothelial function and oxidative stress parameters in patients with hypercholesterolemia were analyzed. Significant improvements were reported in inflammatory (IL-1β), endothelial function (ET-1, E-selectin), and oxidative stress markers (ox-LDL, 8-isoprostane). Food matrix, PS profile, dosage, and intervention duration seemed not to decisively influence outcomes. Small population size and lack of simultaneous assessment of the parameters were the main limitations. PS show promising cardiovascular protection, although future research should include serum PS profiling and gut microbiota analysis to evaluate potential correlations with cardiovascular bioactivity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.